Stocks and Investing Stocks and Investing
Wed, December 16, 2015
Tue, December 15, 2015
Mon, December 14, 2015
Fri, December 11, 2015
Thu, December 10, 2015
Wed, December 9, 2015
Tue, December 8, 2015
Mon, December 7, 2015
Fri, December 4, 2015
Thu, December 3, 2015
Wed, December 2, 2015
Tue, December 1, 2015
Mon, November 30, 2015
Wed, November 25, 2015
Tue, November 24, 2015
Mon, November 23, 2015
Sun, November 22, 2015
Fri, November 20, 2015
Thu, November 19, 2015
Wed, November 18, 2015
Tue, November 17, 2015
Mon, November 16, 2015
Fri, November 13, 2015
Thu, November 12, 2015
Wed, November 11, 2015
Tue, November 10, 2015

Paul Matteis Maintained (ALNY) at Buy with Increased Target to $152 on, Nov 10th, 2015


Published on 2024-10-25 10:34:02 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $151 to $152 on, Nov 10th, 2015.

Paul has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $115 on, Friday, August 7th, 2015


This is the rating of the analyst that currently disagrees with Paul


  • Rahul Jasuja of "FBR Capital" Initiated at Buy and Held Target at $180 on, Tuesday, August 11th, 2015